Victrex (LON:VCT) Stock Rating Lowered by Deutsche Bank Aktiengesellschaft

Victrex (LON:VCT - Get Free Report) was downgraded by analysts at Deutsche Bank Aktiengesellschaft to a "hold" rating in a research note issued on Tuesday, MarketBeat.com reports. They presently have a GBX 850 ($11.47) price objective on the stock, down from their previous price objective of GBX 990 ($13.35). Deutsche Bank Aktiengesellschaft's price objective suggests a potential upside of 17.34% from the stock's current price.

Separately, JPMorgan Chase & Co. decreased their price objective on shares of Victrex from GBX 940 ($12.68) to GBX 818 ($11.03) and set a "neutral" rating for the company in a research note on Wednesday.

Victrex Stock Down 0.5%

Shares of VCT traded down GBX 3.60 ($0.05) on Tuesday, reaching GBX 724.40 ($9.77). The company's stock had a trading volume of 171,582 shares, compared to its average volume of 414,972. The company has a current ratio of 4.39, a quick ratio of 1.99 and a debt-to-equity ratio of 10.93. Victrex has a twelve month low of GBX 667.62 ($9.01) and a twelve month high of GBX 1,160 ($15.65). The stock has a market capitalization of £631.91 million, a PE ratio of 20.58, a PEG ratio of 1.92 and a beta of 0.69. The firm has a fifty day moving average of GBX 793.01 and a 200-day moving average of GBX 887.05.

Victrex (LON:VCT - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.30) earnings per share for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. Equities analysts predict that Victrex will post 73.1078905 EPS for the current year.

Insider Activity

In related news, insider Dame Vivienne Cox bought 2,747 shares of Victrex stock in a transaction dated Tuesday, July 8th. The stock was purchased at an average cost of GBX 721 ($9.73) per share, with a total value of £19,805.87 ($26,717.75). Also, insider David Thomas bought 1,158 shares of Victrex stock in a transaction dated Tuesday, May 13th. The shares were bought at an average cost of GBX 846 ($11.41) per share, with a total value of £9,796.68 ($13,215.54). Company insiders own 1.64% of the company's stock.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.